editorijrpas@gmail.com

International Journal of Research in Pharmacy and Allied Science

ISSN: 2583-6544 | Issues per year: Monthly | Indexed In: Google Scholar, CORE, ScienceOpen, Researchgate

ISSN:2583-6544

Abstract View

The Review on Innovations in Mouth Dissolving Films: Enhancing Drug Delivery and Patient Compliance

Author(s): Mr. Faizan Ahmed¹, Mujahid Ahmed Haroon Rasheed², Pathan Junaid Moinuddin³, Obaidurraheman Mohammed Saleem⁴, ⁵

Email(s): ¹pathanjunaid2021@gmail.com

Address:

Royal College of Pharmaceutical Education and Research, Syne Khurd Malegaon.

Published In: Volume - 3, Issue - 2, Year - 2024

DOI: Not Available

View HTML

View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Mouth-dissolving films (MDFs) have emerged as a promising drug delivery system, revolutionizing the pharmaceutical industry by addressing challenges related to conventional dosage forms. This paper explores recent innovations in MDFs, focusing on enhancing drug delivery efficacy and improving patient compliance. The review discusses various formulation techniques, such as solvent casting and hot-melt extrusion, which contribute to the development of MDFs with improved mechanical properties and drug release profiles. Furthermore, the impact of different polymers, plasticizers, and disintegrating agents on the performance of MDFs is examined. Special attention is given to the incorporation of novel drug delivery technologies, including nanostructured systems and mucoadhesive polymers, to enhance the bioavailability of drugs through the oral mucosa. Additionally, the paper highlights the influence of taste-masking strategies on patient acceptance and compliance. Overall, this comprehensive review provides insights into the current state of innovations in MDFs, shedding light on their potential to overcome challenges associated with traditional drug delivery systems.

Keywords:

Cite this article:
Mr. Faizan Ahmed, Mujahid Ahmed Haroon Rasheed, Pathan Junaid Moinuddin, Obaidurraheman Mohammed Saleem.The Review on Innovations in Mouth Dissolving Films: Enhancing Drug Delivery and Patient Compliance.IJRPAS, March-April 2024; 3(2):58-71

1. Silberstein S, Loder E, Diamond S, Reed M, Bigal M, Lipton R. Probable Migraine in the United States: Results Of The American Migraine Prevalence and Prevention (AMPP) Study.Cephalalgia. 2007 Mar;27(3):220–9.

2. Goadsby PJ. Migraine: diagnosis and management. Intern Med J. 2003 Sep;33(9–10):436–42.

3. Kelman L. Migraine Pain Location: A Tertiary Care Study of 1283 Migraineurs. Headache J Head Face Pain. 2005 Sep;45(8):1038–47.

4. Buse DC, Greisman JD, Baigi K, Lipton RB. Migraine Progression: A Systematic Review. Headache J Head Face Pain. 2019 Mar;59(3):306–38.

5. Becker WJ. Botulinum Toxin in the Treatment of Headache. Toxins. 2020 Dec 17;12(12):803.

6. Adams AM, Serrano D, Buse DC, Reed ML, Marske V, Fanning KM, et al. The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results. Cephalalgia. 2015 Jun;35(7):563–78.

7. Charles A. The pathophysiology of migraine: implications for clinical management. Lancet Neurol. 2018 Feb 1;17(2):174–82.

8. Pietrobon D, Moskowitz MA. Pathophysiology of Migraine. Annu Rev Physiol. 2013 Feb 10;75(1):365–91.

9. Diener HC, Charles A, Goadsby PJ, Holle D. New therapeutic approaches for the prevention and treatment of migraine. Lancet Neurol. 2015;14(10):1010–22.

10. Burch R, Rayhill M. Acute Treatment for Migraine: Contemporary Treatments and Future Directions. JAMA. 2021 Jun 15;325(23):2346.

11. Serrano D, Manack AN, Reed ML, Buse DC, Varon SF, Lipton RB. Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Value Health. 2013;16(1):31–8.

12. Bala R, Pawar P, Khanna S, Arora S. Orally dissolving strips: A new approach to oral drug delivery system. Int J Pharm Investig. 2013;3(2):67.

13. Arya A, Chandra A, Sharma V, Pathak K. Fast dissolving oral films: an innovative drug delivery system and dosage form. Int J ChemTech Res. 2010;2(1):576–83.

14. Hoffmann EM, Breitenbach A, Breitkreutz J. Advances in orodispersible films for drug delivery. Expert Opin Drug Deliv. 2011 Mar;8(3):299–316.

15. Bhyan B, Jangra S, Kaur M, Singh H. Orally fast dissolving films: innovations in formulation and technology. Int J Pharm Sci Rev Res. 2011;9(2):9–15.

16. Gupta MK, Gupta R, Khunteta A, Swarnkar SK. An overview of mouth dissolving films: Formulation aspects. Int J Pharm Biol Sci Arch. 2017;5(5):01–18.

17. Ghodake PP, Karande KM, Osmani RA, Bhosale RR, Harkare BR, Kale BB. Mouth dissolving films: Innovative vehicle for oral drug delivery. polymer. 2013;9:20.

18. Saini S, Nanda A, Hooda M, Chaudhary K. Fast dissolving films (FDF): innovative drug delivery system. Pharmacologyonline. 2011;2:919–28.

19. Mandeep K, Rana AC, Nimrata S. Fast Dissolving Films: An Innovative Drug Delivery System. Int J Pharm Res Allied Sci [Internet]. 2013 [cited 2023 Nov 6];2(1). Available from: https://ijpras.com/storage/models/article/M3DS86AZ8wmKTam7OdNAvC45IH2283UVqKeSU 7kz3njQc2TQuScjZrSexevE/fast-dissolving-films-an-innovative-drug-delivery-system.pdf

20. Patil PC, Shrivastava SK, S. V, P. A. ORAL FAST DISSOLVING DRUG DELIVERY SYSTEM: A MODERN APPROACH FOR PATIENT COMPLIANCE. Int J Drug Regul Aff. 2018 Feb 12;2(2):49–60.

21. rights are reserved by Ms A, Amin PM. Oral Film Technology: Challenges and Future Scope for Pharmaceutical Industry. 2015 [cited 2023 Dec 5]; Available from:https://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=b26960f7cb8a19489bc3b672 9ab83debcb43

Related Images:

Recent Images

RPHPLC Method for Concurrent Determination of Haloperidol and Trihexyphenidyl in API and Combined Tablet Formulations

A review on HPLC Methods for Estimation of Travoprost in Combined and Single Pharmaceutical formulation and Bulk

To Study number and types of refund Medicines from different Wards of Hospital to the In-Patient Pharmacies

A Novel RP-HPLC Analytical Method Development and Validation of Berberine In Bulk and Polyherbal Formulation

Formulation and Evaluation of A Polyherbal Cough Syrup with Potential Anti-Obesity Effects

Formulation and evaluation of Herbal Face Cream

Formulation and In-vitro Evaluation of Cold Cream

Design and Optimization of Extended-Release Mini-Tablets of Metoprolol Succinate Using Okra Stalk Powder and HPMC K100 M as Release Modifiers

Comprehensive review on Alfuzosin quantification: Analytical techniques and the evolution of AQbD in method development